A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Binge Eating Disorder
This 6-month double-blind, placebo-controlled pilot study evaluated the effects of chromium picolinate supplementation on binge eating disorder (BED) in 24 overweight adults. Participants were randomized to receive either 1000 μg/day (high dose), 600 μg/day (moderate dose) of chromium picolinate, or placebo. Both chromium groups exhibited significant reductions in fasting glucose